Skip to main content
OpenTrials
Completed

NCT Number: NCT05976698

LSD-Perceptual-Choice-Study

The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Psychiatric Clinics Basel

Basel, 4002, Switzerland

About this study

The study team will subject healthy participants to multiple perceptual decision-making tasks after the administration of low doses of LSD (d-lysergic acid diethylamide) as a pharmacological challenge. The investigators want to illuminate the behavioral and neural effects of psychedelics on prior beliefs and evidence processing. Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Subjects will be under continuous supervision until approximately 4.5h after substance administration. The participants are asked to perform the following cognitive tasks alongside EEG measurement after administration of either LSD or placebo: Changepoint task, history bias task, surround suppression task, auditory steady-state response paradigm, motor localizer task.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Willingness to adhere to the study protocol and sign the consent form
  • ≥ 18 and ≤ 65 years of age at Screening
  • Body mass index 18-29
  • Fluent understanding of German
  • Normal or corrected-to-normal vision
  • Willingness to not operate a traffic vehicle or heavy machinery 24 hours after substance administration
  • Willingness to refrain from taking illicit psychoactive substances, including cannabis, for the duration of the study
  • Willingness to not consume more than one alcoholic standard drink the night before the study sessions and not consume alcohol for 24 h after each study session
  • Willingness to abstain from xanthine-based liquids from the evenings prior to the study sessions and during the sessions
  • Willingness to use effective birth-control throughout the study duration
  • Adequate task performance in the decision-making tasks during a practice session in the screening visit

Exclusion criteria

  • Recent (<30 days) or current participation in another clinical trial
  • Women that are pregnant, nursing, or planning to become pregnant during the study period
  • Current use of contraindicated/psychoactive medications or illicit drugs
  • Lifetime use of classical psychedelics more than 20 times, or any time within the previous two months
  • Consumption of >5 cigarettes per day or >20 alcoholic standard drinks per week
  • Severe chronic or acute medical condition
  • Hypertension (>140/90 mmHg) or hypotension (<85mmHg systolic)
  • Current or lifetime major mental health disorder
  • Personal or family (first-degree) history of a primary psychotic disorder

Treatment and study plan

LSD 10 μg

Drug

0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

LSD 20 μg

Drug

0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Placebo

Drug

0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.

Primary outcomes

  1. Change in changepoint task

    Time frame: three times (once on each of the three test days; interval between test days at least 7 days)

    Using the changepoint task, it is examined how explicit expectations about upcoming stimuli are derived from the perceptual history and how they influence the perceptual decision in a volatile environment.

    The study team utilizes an established computerized task and analysis pipeline including a behavioral modeling strategy based on Bayesian inference. The task requires participants to view a train of stimuli consisting of checkerboards presented on a half-circle gradient either more on the right or more on the left side of a fixation cross. Each checkerboard represents information about whether stimuli are currently more likely to appear on the right or left side of the screen. The participants have to indicate by button press, whether they believe the right or the left side is active. Task difficulty is fixed.

  2. Change in history bias task

    Time frame: three times (once on each of the three test days; interval between test days at least 7 days)

    With the history bias task, the study team investigates how implicit expectations about upcoming stimuli are derived from perceptual history and how they bias perceptual discrimination.

    In each trial, two circular gratings will be presented concurrently on the left and right sides of a fixation cross. After complete stimulus presentation, the participants indicate by button press which of the two gratings they believe had the stronger contrast in the trial (left vs. right). Task difficulty will be adjusted individually using an online quest staircase procedure, such that participants will always perform at their 75% accuracy level.

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Collaborators

  • University Psychiatric Clinics Basel
  • University of Basel

Registry information

Official study title

Effects of LSD on Perceptual Decision-making in Healthy Subjects

Acronym: LUCY

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 4, 2023
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.